Clinical Trial Update: Dapagliflozin Plus Pioglitazone in T1DM [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the combination of dapagliflozin and pioglitazone in Type 1 Diabetes Mellitus. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Actos (Pioglitazone)
• FARXIGA (dapagliflozin)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Type 1 Diabetes Mellitus | Phase 4 | Status: RECRUITING